Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04097743 · ClinicalTrials.gov registry record · NA
Pain Catastrophizing and Prescription Opioid Craving
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT04097743: Clinical Trial NA study, sponsored by Stanford University.
NCT04097743 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04097743, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
Adherence to prescription opioid and opioid tapering as indicated are critical for safe chronic opioid therapy for chronic pain, but this can be difficult for patients experiencing prescription opioid craving. Because pain catastrophizing is proposed as a possible treatment target by our and others' preliminary results, the proposed study aims to determine whether pain catastrophizing is a treatment target to reduce prescription opioid craving and to investigate whether negative affect and stress hormones are potential mediators. The findings from the current study will inform whether a psychology intervention to lower pain catastrophizing will reduce opioid craving, and whether psychological and physical distress as well as cognitive function will be potential mediators of the treatment effect.
Interventions
- BEHAVIORAL Coping Statement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2024-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04097743
The ClinicalTrials.gov registry entry for NCT04097743 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coping Statement is the first listed.
NCT04097743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04097743 about?
NCT04097743 is a clinical study titled "Pain Catastrophizing and Prescription Opioid Craving". Adherence to prescription opioid and opioid tapering as indicated are critical for safe chronic opioid therapy for chronic pain, but this can be difficult for patients experiencing prescription opioid craving. Because pain catastrophizing is proposed as a possible treatment target by our and others'...
What is the current status of trial NCT04097743?
This trial is currently terminated. It is a NA study. The enrollment target is 93 participants. The study started on 2021-06-29. Estimated completion is 2024-12-10.
What interventions are being tested in trial NCT04097743?
The interventions under investigation include: Coping Statement (BEHAVIORAL).
Who is sponsoring clinical trial NCT04097743?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.